Profile data is unavailable for this security.
About the company
Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in research and development, manufacturing and sale of oncology drugs and formulations. Its products consist of oncology and non-oncology active pharmaceutical ingredients (APIs), oncology formulations, biosimilars, ophthalmic, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales and transdermal patches. It supplies oncology APIs and intermediates. Its oncology/non-oncology APIs include Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib HCL, and Irinotecan HCL Trihydrate for various regulated markets, including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-oncology APIs products include Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India. It is also engaged in manufacturing and sale of Lenvatinib Capsules under the brand name Lenshil.
- Revenue in INR (TTM)11.23bn
- Net income in INR-6.71m
- Incorporated1987
- Employees1.03k
- LocationShilpa Medicare LtdShilpa House#12-6-214/A1,, Hyderabad Road,RAICHUR 584135IndiaIND
- Phone+91 8 532238704
- Fax+91 8 532238876
- Websitehttps://www.vbshilpa.com/
Mergers & acquisitions
Acquired company | SHILPAMED:NSI since announced | Transaction value |
---|---|---|
Pilnova Pharma Inc | 41.50% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SeQuent Scientific Ltd | 13.70bn | -358.69m | 28.63bn | 478.00 | -- | 4.37 | 89.67 | 2.09 | -1.45 | -1.45 | 56.27 | 26.32 | 0.8925 | 2.19 | 4.05 | -- | -1.93 | 1.09 | -3.27 | 1.76 | 44.53 | 42.74 | -2.16 | 1.18 | 0.7602 | 0.1376 | 0.4062 | -- | -3.60 | 5.68 | 70.40 | -- | 6.96 | -- |
Innova Captab Ltd | -100.00bn | -100.00bn | 28.81bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 15.72 | -- | 6.26 | -- | -- | -- |
Indoco Remedies Ltd | 18.17bn | 984.70m | 29.04bn | 6.10k | 29.95 | 2.62 | 15.38 | 1.60 | 10.52 | 10.52 | 193.15 | 120.38 | 0.9557 | 1.65 | 4.80 | -- | 5.10 | 6.88 | 7.02 | 9.85 | 69.23 | 66.66 | 5.34 | 6.93 | 0.9825 | 4.01 | 0.377 | 12.67 | 8.91 | 13.41 | -30.78 | -- | 34.54 | 37.97 |
Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 29.72bn | 1.23k | -- | 93.98 | -- | -- | -- | -- | -- | 12.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.8228 | -- | 0.2681 | -- | 43.84 | -- | 77.37 | -- | -- | -- |
Supriya Lifescience Ltd | 5.54bn | 1.20bn | 30.37bn | 392.00 | 25.21 | -- | 22.44 | 5.48 | 14.97 | 14.97 | 68.93 | -- | -- | -- | -- | 14,144,410.00 | -- | 20.77 | -- | 29.06 | 61.94 | 55.83 | 21.72 | 24.33 | -- | 63.63 | -- | 2.02 | -13.04 | 16.70 | -40.81 | 59.41 | 85.55 | -- |
Dishman Carbogen Amcis Ltd | 25.80bn | -1.54bn | 30.56bn | 1.30k | -- | -- | 20.74 | 1.18 | -9.84 | -9.84 | 164.35 | -- | -- | -- | -- | 19,919,850.00 | -- | 0.4699 | -- | 0.5665 | 76.93 | 74.36 | -5.98 | 1.82 | -- | -0.1245 | -- | 202.76 | 12.72 | 7.32 | -265.46 | -- | 21.54 | -- |
Gufic BioSciences Ltd | 7.85bn | 841.95m | 34.68bn | 1.63k | 40.12 | -- | 32.88 | 4.42 | 8.62 | 8.62 | 80.38 | -- | -- | -- | -- | 4,820,074.00 | -- | 12.30 | -- | 23.08 | 51.08 | 44.91 | 10.73 | 9.84 | -- | 8.22 | -- | 1.39 | -11.36 | 17.47 | -16.84 | 37.06 | 86.82 | 14.87 |
Hikal Ltd | 17.85bn | 696.00m | 36.18bn | 2.14k | 51.94 | 3.05 | 19.33 | 2.03 | 5.65 | 5.65 | 144.77 | 96.32 | 0.7325 | 2.66 | 3.60 | -- | 2.86 | 5.07 | 4.03 | 7.51 | 53.79 | 47.22 | 3.90 | 5.86 | 0.8761 | 2.65 | 0.4077 | 16.88 | -11.79 | 2.34 | -11.20 | -7.55 | 9.72 | 0.00 |
Unichem Laboratories Ltd | 16.75bn | 145.69m | 39.59bn | 3.12k | 272.14 | -- | 30.37 | 2.36 | 2.07 | 2.07 | 234.69 | -- | -- | -- | -- | 5,364,373.00 | -- | -1.38 | -- | -1.66 | 59.94 | 56.15 | 0.8696 | -3.60 | -- | -0.9613 | -- | -- | 5.76 | 10.51 | -711.67 | -- | -22.60 | -- |
Advanced Enzyme Technologies Ltd | 6.24bn | 1.33bn | 41.53bn | 338.00 | 31.13 | 3.14 | 24.12 | 6.66 | 11.93 | 11.93 | 55.83 | 118.41 | 0.4219 | 1.06 | 6.27 | -- | 9.26 | 10.82 | 10.23 | 11.93 | 76.83 | 72.81 | 21.95 | 24.59 | 6.22 | 57.81 | 0.0334 | 15.17 | 15.39 | 8.26 | 26.19 | 3.72 | 27.85 | 53.42 |
Aarti Drugs Ltd | 25.29bn | 1.71bn | 45.43bn | 1.50k | 26.55 | 3.54 | 20.37 | 1.80 | 18.61 | 18.61 | 274.44 | 139.40 | 1.04 | 3.35 | 3.22 | -- | 7.07 | 9.73 | 10.98 | 15.74 | 33.65 | 24.96 | 6.79 | 8.25 | 1.05 | 7.91 | 0.3056 | -- | -6.90 | 10.13 | 3.07 | 13.82 | 24.96 | -- |
Shilpa Medicare Ltd | 11.23bn | -6.71m | 48.08bn | 1.03k | -- | -- | 45.22 | 4.28 | -0.0714 | -0.0714 | 131.44 | -- | -- | -- | -- | 10,873,050.00 | -- | 3.89 | -- | 4.92 | 64.42 | 60.22 | -0.0538 | 9.29 | -- | 1.16 | -- | 10.65 | -8.33 | 5.82 | -153.54 | -- | 14.58 | -- |
Aarti Pharmalabs Ltd | 18.53bn | 2.17bn | 52.51bn | 1.40k | 24.21 | 2.99 | 18.10 | 2.83 | 23.94 | 23.94 | 204.45 | 193.89 | 0.7698 | 1.64 | 3.86 | -- | 9.01 | -- | 12.30 | -- | 44.90 | -- | 11.71 | -- | 1.01 | 18.17 | 0.1397 | -- | -4.76 | -- | 12.10 | -- | -- | -- |
Orchid Pharma Ltd | 8.12bn | 1.25bn | 55.55bn | 838.00 | 38.43 | -- | 34.95 | 6.84 | 28.50 | 26.84 | 175.33 | -- | -- | -- | -- | 9,691,729.00 | -- | -1.07 | -- | -1.96 | 41.49 | 45.87 | 15.63 | -3.52 | -- | 4.34 | -- | -- | 19.00 | -0.6456 | 187.87 | -- | 68.72 | -- |
Blue Jet Healthcare Ltd | -100.00bn | -100.00bn | 64.69bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.49 | -- | -11.88 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
ICICI Prudential Asset Management Co. Ltd.as of 30 Apr 2024 | 3.22m | 3.30% |
Bandhan Asset Management Co. Ltd.as of 30 Apr 2024 | 1.25m | 1.28% |
Dimensional Fund Advisors LPas of 09 May 2024 | 419.57k | 0.43% |
WhiteOak Capital Asset Management Ltd.as of 30 Apr 2024 | 409.84k | 0.42% |
SSgA Funds Management, Inc.as of 09 May 2024 | 191.60k | 0.20% |
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 2024 | 72.53k | 0.07% |
Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 40.23k | 0.04% |
American Century Investment Management, Inc.as of 09 May 2024 | 27.55k | 0.03% |
ITI Asset Management Ltd. (India)as of 30 Apr 2024 | 27.11k | 0.03% |
DFA Australia Ltd.as of 31 Mar 2024 | 7.33k | 0.01% |